Recurring mutations found by sequencing an acute myeloid leukemia genome (Q24634204)

Sean D McGrath

10

0 references

Timothy A. Graubert

Timothy A Graubert

55

0 references

Michael H Tomasson

Michael H Tomasson

47

0 references

Joshua F. McMichael

30

Joshua F McMichael

0 references

Richard K. Wilson

57

Richard K Wilson

0 references

Kim Delehaunty

9

Kim D Delehaunty

0 references

Lucinda Fulton

11

Lucinda A Fulton

0 references

Devin P. Locke

12

Devin P Locke

0 references

Michael D McLellan

5

Michael D McLellan

0 references

Dan Koboldt

7

Daniel C Koboldt

0 references

Timothy Ley

58

Timothy J Ley

0 references

Heather Schmidt

37

Heather Schmidt

0 references

Craig S. Pohl

33

Craig S Pohl

0 references

Joelle Kalicki

42

Joelle Kalicki

0 references

Glendoria Elliott

43

Glendoria Elliott

0 references

Todd Wylie

18

Todd Wylie

0 references

David Dooling

3

David J Dooling

0 references

Tammi L Vickery

15

Tammi L Vickery

0 references

Jody S Robinson

17

Jody S Robinson

0 references

Lynn Carmichael

20

Lynn Carmichael

0 references

Xiaoqi Shi

35

Xiaoqi Shi

0 references

Yuzhu Tang

38

Yuzhu Tang

0 references

Carrie Haipek

39

Carrie Haipek

0 references

Madeline E Wiechert

40

Madeline E Wiechert

0 references

Rhonda E Ries

44

Rhonda E Ries

0 references

Jacqueline E Payton

45

Jacqueline E Payton

0 references

Jack Baty

49

Jack Baty

0 references

Rakesh Nagarajan

52

Rakesh Nagarajan

0 references

John DiPersio

56

John F DiPersio

0 references

Anthony M Brummett

28

Anthony M Brummett

0 references

author name string

Li Ding

2

0 references

David E Larson

4

0 references

Ken Chen

6

0 references

Robert S Fulton

8

0 references

Vincent J Magrini

13

0 references

Rachel M Abbott

14

0 references

Jerry S Reed

16

0 references

Scott M Smith

19

0 references

James M Eldred

21

0 references

Christopher C Harris

22

0 references

Jason Walker

23

0 references

Joshua B Peck

24

0 references

Feiyu Du

25

0 references

Adam F Dukes

26

0 references

Gabriel E Sanderson

27

0 references

Eric Clark

29

0 references

Rick J Meyer

31

0 references

Jonathan K Schindler

32

0 references

John W Wallis

34

0 references

Ling Lin

36

0 references

Jolynda V Ivy

41

0 references

Peter Westervelt

46

0 references

Mark A Watson

48

0 references

Sharon Heath

50

0 references

William D Shannon

51

0 references

Daniel C Link

53

0 references

Matthew J Walter

The New England Journal of Medicine

54

0 references

language of work or name

English

0 references

publication date

10 September 2009

0 references

published in

0 references

volume

361

0 references

issue

11

0 references

page(s)

1058-66

0 references

on focus list of Wikimedia project

ScienceSource

0 references

cites work

IDH1 and IDH2 mutations in gliomas

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3201812

DNA sequencing of a cytogenetically normal acute myeloid leukaemia genome

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3201812

Accurate whole human genome sequencing using reversible terminator chemistry

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3201812

Mapping short DNA sequencing reads and calling variants using mapping quality scores

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3201812

Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3201812

Mutations and treatment outcome in cytogenetically normal acute myeloid leukemia

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3201812

The consensus coding sequences of human breast and colorectal cancers

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3201812

Clinical outcome of de novo acute myeloid leukaemia patients with normal cytogenetics is affected by molecular genetic alterations: a concise review

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3201812

Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461)

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3201812

A turning point in cancer research: sequencing the human genome

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3201812

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3201812

Glioma-derived mutations in IDH1 dominantly inhibit IDH1 catalytic activity and induce HIF-1alpha

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3201812

Acquired copy number alterations in adult acute myeloid leukemia genomes

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3201812

IDH1 mutations at residue p.R132 (IDH1(R132)) occur frequently in high-grade gliomas but not in other solid tumors

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3201812

Incorporating FLT3 inhibitors into acute myeloid leukemia treatment regimens

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3201812

High BAALC expression associates with other molecular prognostic markers, poor outcome, and a distinct gene-expression signature in cytogenetically normal patients younger than 60 years with acute myeloid leukemia: a Cancer and Leukemia Group B (CAL

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3201812

Familial myelodysplasia and acute myeloid leukaemia--a review

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3201812

Distinct patterns of mutations occurring in de novo AML versus AML arising in the setting of severe congenital neutropenia

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3201812

Use of gene-expression profiling to identify prognostic subclasses in adult acute myeloid leukemia

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3201812

Accounting for human polymorphisms predicted to affect protein function

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3201812

The predictive value of hierarchical cytogenetic classification in older adults with acute myeloid leukemia (AML): analysis of 1065 patients entered into the United Kingdom Medical Research Council AML11 trial

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3201812

Haploinsufficiency of CBFA2 causes familial thrombocytopenia with propensity to develop acute myelogenous leukaemia

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3201812

High EVI1 levels predict adverse outcome in acute myeloid leukemia: prevalence of EVI1 overexpression and chromosome 3q26 abnormalities underestimated.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3201812

Mutational analysis of IDH1 codon 132 in glioblastomas and other common cancers

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3201812

High meningioma 1 (MN1) expression as a predictor for poor outcome in acute myeloid leukemia with normal cytogenetics

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3201812

Disclosure of Candidate Genes in Acute Myeloid Leukemia With Complex Karyotypes Using Microarray-Based Molecular Characterization

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3201812

Prognostically useful gene-expression profiles in acute myeloid leukemia.

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3201812

Oligonucleotide array-CGH reveals cryptic gene copy number alterations in karyotypically normal acute myeloid leukemia

28 November 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19657110

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

DNA profiling analysis of 100 consecutive de novo acute myeloid leukemia cases reveals patterns of genomic instability that affect all cytogenetic risk groups

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19657110

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

High Expression Levels of theETS-Related Gene,ERG, Predict Adverse Outcome and Improve Molecular Risk-Based Classification of Cytogenetically Normal Acute Myeloid Leukemia: A Cancer and Leukemia Group B Study

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19657110